Advertisement

Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

03:07 EDT 22nd May 2013 | BioPortfolio

Summary

The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer.

Description

The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend chemotherapy for up to an additional 12 months.

Group 2 receives standard chemotherapy in the same manner as group 1. In addition, they receive 12 months of oral or IV nutritional supplements.

Study Design

Allocation: Randomized, Control: Active Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Ovarian Cancer

Intervention

oral & IV antioxidant vitamins and minerals, chemotherapy, paclitaxel and carboplatin chemotherapy

Location

University of Kansas Medical Center
Kansas City
Kansas
United States
66160

Status

Active, not recruiting

Source

University of Kansas

Results (where available)

View Results

Links

Medical and Biotech [MESH] Definitions

Vindesine

Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).

Chemotherapy, Adjuvant

Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

Karnofsky Performance Status

A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.

Milk

The white liquid secreted by the mammary glands. It contains proteins, sugar, lipids, vitamins, and minerals.

Cystaphos

Proposed as an adjuvant to cancer chemotherapy; may have radiation protective properties.

Clinical Trials [ 1215 Associated Clinical Trials listed on BioPortfolio]

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

It has been suggested that a low dietary intake of antioxidant vitamins and minerals increases the incidence rate of cardiovascular disease and cancer. To date, however, the published resu...

Safety of Antioxidants During GYN Cancer Care

It is known that people with cancer are using antioxidant vitamins at high rates. It is not known if these vitamins are safe to use during cancer treatment. It is not known if common vitam...

Micronutrients and Child Health Study

The purpose of this study is to determine to what extent supplementation with zinc and other micronutrients are efficacious in preventing malaria in young Tanzanian children.

Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children

To determine the effect of medical food on reducing asthma symptoms in asthmatic children.

Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals in Improvement of Stress and Fatigue

We hope that with the drug, patients obtain reduced levels of stress and fatigue, according to the scales that we use in the study. Hopefully the results of the treated group are significa...

PubMed Articles [ 15010 Associated PubMed Articles listed on BioPortfolio]

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study.

PURPOSE The primary goal of this open-label, multicenter, randomized phase III trial was to determine whether treatment with carboplatin plus the oral fluoropyrimidine derivative S-1 was noninferior v...

Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin.

PURPOSE: The aim of the present study was to investigate, in ovarian carcinoma cases, the predictive association between the treatment-free interval (TFI) after an initial paclitaxel plus carboplatin...

Efficacy of Carboplatin and Paclitaxel with Bevacizumab as Salvage Chemotherapy for Non-small Cell Lung Cancer after Failure of Platinum-doublet Chemotherapy.

Salvage chemotherapy using carboplatin (C), paclitaxel (P), and bevacizumab (BEV) for patients with pre-treated, advanced non-squamous non-small cell lung cancer (NSCLC) has not yet been reported. Pat...

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial.

PURPOSE Carboplatin/paclitaxel is the standard first-line chemotherapy for patients with advanced ovarian cancer. Multicentre Italian Trials in Ovarian Cancer-2 (MITO-2), an academic multicenter phase...

Primary squamous cell carcinoma associated with ovarian endometriosis: a case report and literature review.

Primary squamous cell carcinoma (SCC) associated with ovarian endometriosis is extremely rare and has a poor prognosis due to insufficient information on the optimal postoperative treatment. Here, we...

More From BioPortfolio on "Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants"

Search BioPortfolio: